Is Medtronic Stock Underperforming the Nasdaq?

Galway, Ireland-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States and internationally. The company has a market cap of $94.8 billion and operates through Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes segments.

Companies with a market cap of $10 billion or more are typically referred to as “big-cap stocks.” MDT fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the medical devices industry.